HighTower Advisors’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $696K | Sell |
18,083
-476
| -3% | -$19.6K | ﹤0.01% | 2447 |
|
|
2025
Q4 | $763K | Sell |
18,559
-2,887
| -13% | -$114K | ﹤0.01% | 2310 |
|
|
2025
Q3 | $798K | Sell |
21,446
-1,031
| -5% | -$37.5K | ﹤0.01% | 2266 |
|
|
2025
Q2 | $820K | Sell |
22,477
-3,508
| -14% | -$127K | ﹤0.01% | 2145 |
|
|
2025
Q1 | $1M | Sell |
25,985
-544
| -2% | -$21.6K | ﹤0.01% | 1959 |
|
|
2024
Q4 | $1.01M | Sell |
26,529
-3,750
| -12% | -$150K | ﹤0.01% | 1965 |
|
|
2024
Q3 | $1.27M | Sell |
30,279
-1,973
| -6% | -$81.9K | ﹤0.01% | 1779 |
|
|
2024
Q2 | $1.31M | Sell |
32,252
-1,084
| -3% | -$43.1K | ﹤0.01% | 1704 |
|
|
2024
Q1 | $1.38M | Sell |
33,336
-434
| -1% | -$18.2K | ﹤0.01% | 1622 |
|
|
2023
Q4 | $1.36M | Sell |
33,770
-3,628
| -10% | -$139K | ﹤0.01% | 1674 |
|
|
2023
Q3 | $1.47M | Sell |
37,398
-711
| -2% | -$28.3K | ﹤0.01% | 1554 |
|
|
2023
Q2 | $1.54M | Sell |
38,109
-380
| -1% | -$15.6K | ﹤0.01% | 1504 |
|
|
2023
Q1 | $1.61M | Buy |
38,489
+216
| +0.6% | +$9.09K | ﹤0.01% | 1417 |
|
|
2022
Q4 | $1.67M | Sell |
38,273
-3,013
| -7% | -$128K | ﹤0.01% | 1382 |
|
|
2022
Q3 | $1.61M | Buy |
41,286
+3,128
| +8% | +$133K | ﹤0.01% | 1359 |
|
|
2022
Q2 | $1.61M | Buy |
38,158
+2,573
| +7% | +$112K | ﹤0.01% | 1371 |
|
|
2022
Q1 | $1.63M | Sell |
35,585
-1,066
| -3% | -$47.2K | ﹤0.01% | 1491 |
|
|
2021
Q4 | $1.78M | Sell |
36,651
-134
| -0.4% | -$6.34K | ﹤0.01% | 1428 |
|
|
2021
Q3 | $1.76M | Buy |
36,785
+218
| +0.6% | +$10.6K | ﹤0.01% | 1330 |
|
|
2021
Q2 | $1.78M | Buy |
36,567
+2,439
| +7% | +$117K | 0.01% | 1289 |
|
|
2021
Q1 | $1.58M | Sell |
34,128
-630
| -2% | -$29.9K | 0.01% | 1264 |
|
|
2020
Q4 | $1.66M | Sell |
34,758
-882
| -2% | -$40K | 0.01% | 992 |
|
|
2020
Q3 | $1.53M | Buy |
35,640
+67
| +0.2% | +$2.87K | 0.01% | 1005 |
|
|
2020
Q2 | $1.44M | Buy |
35,573
+7,618
| +27% | +$307K | 0.01% | 944 |
|
|
2020
Q1 | $1.01M | Sell |
27,955
-5,551
| -17% | -$221K | 0.01% | 1006 |
|
|
2019
Q4 | $1.43M | Buy |
33,506
+1,413
| +4% | +$56K | 0.01% | 974 |
|
|
2019
Q3 | $1.22M | Buy |
32,093
+2,165
| +7% | +$83.3K | 0.01% | 1081 |
|
|
2019
Q2 | $1.17M | Sell |
29,928
-2,580
| -8% | -$98.1K | 0.01% | 1118 |
|
|
2019
Q1 | $1.29M | Buy |
32,508
+3,283
| +11% | +$130K | 0.01% | 1027 |
|
|
2018
Q4 | $1.07M | Sell |
29,225
-421
| -1% | -$16.5K | 0.01% | 1012 |
|
|
2018
Q3 | $1.26M | Buy |
29,646
+1,271
| +4% | +$51.5K | 0.01% | 1026 |
|
|
2018
Q2 | $1.1M | Buy |
28,375
+688
| +2% | +$24.9K | 0.01% | 1076 |
|
|
2018
Q1 | $971K | Buy |
27,687
+17,164
| +163% | +$611K | 0.01% | 1088 |
|
|
2017
Q4 | $383K | Sell |
10,523
-3,867
| -27% | -$140K | ﹤0.01% | 1572 |
|
|
2017
Q3 | $522K | Buy |
14,390
+2,025
| +16% | +$73.7K | ﹤0.01% | 1414 |
|
|
2017
Q2 | $452K | Buy |
+12,365
| New | +$433K | ﹤0.01% | 1415 |
|
Other funds holding BME
1CP
NRW
KIM
HighTower Advisors's BME Position: Q1 2026 in Review
HighTower Advisors reduced its BlackRock Health Sciences Trust (BME) stake by 2.6% in Q1 2026, selling an estimated $19.6K and leaving 18,083 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.
HighTower Advisors first reported a position in BME in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.78M in Q4 2021. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.
- HighTower Advisors held 18,083 shares of BlackRock Health Sciences Trust worth $696K as of Q1 2026.
- HighTower Advisors sold 476 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $19.6K.
- BlackRock Health Sciences Trust made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2447 holding.
- HighTower Advisors first reported a position in BlackRock Health Sciences Trust in Q2 2017 and has held it in 36 quarters since.
- HighTower Advisors's BlackRock Health Sciences Trust position peaked at $1.78M in Q4 2021.
- 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.